nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A11—Methotrexate—germ cell cancer	0.183	0.429	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—germ cell cancer	0.107	0.249	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—germ cell cancer	0.0743	0.174	CbGbCtD
Ceftriaxone—ALB—Methotrexate—germ cell cancer	0.0632	0.148	CbGbCtD
Ceftriaxone—SLC22A8—choroid plexus—germ cell cancer	0.0303	0.141	CbGeAlD
Ceftriaxone—SLC15A2—choroid plexus—germ cell cancer	0.0263	0.123	CbGeAlD
Ceftriaxone—GLUL—optic choroid—germ cell cancer	0.0195	0.0912	CbGeAlD
Ceftriaxone—SLC22A8—optic choroid—germ cell cancer	0.0116	0.0542	CbGeAlD
Ceftriaxone—GLUL—ganglion—germ cell cancer	0.00929	0.0434	CbGeAlD
Ceftriaxone—SLC22A8—urine—germ cell cancer	0.00811	0.0379	CbGeAlD
Ceftriaxone—GLUL—neck—germ cell cancer	0.00528	0.0247	CbGeAlD
Ceftriaxone—GLUL—trigeminal ganglion—germ cell cancer	0.00456	0.0213	CbGeAlD
Ceftriaxone—GLUL—embryo—germ cell cancer	0.00441	0.0206	CbGeAlD
Ceftriaxone—GLUL—brainstem—germ cell cancer	0.00404	0.0189	CbGeAlD
Ceftriaxone—GLUL—eye—germ cell cancer	0.00393	0.0184	CbGeAlD
Ceftriaxone—GLUL—retina—germ cell cancer	0.0039	0.0182	CbGeAlD
Ceftriaxone—GLUL—telencephalon—germ cell cancer	0.00358	0.0167	CbGeAlD
Ceftriaxone—GLUL—skin of body—germ cell cancer	0.00342	0.016	CbGeAlD
Ceftriaxone—GLUL—decidua—germ cell cancer	0.0034	0.0159	CbGeAlD
Ceftriaxone—GLUL—gonad—germ cell cancer	0.00299	0.014	CbGeAlD
Ceftriaxone—GLUL—uterus—germ cell cancer	0.00297	0.0139	CbGeAlD
Ceftriaxone—GLUL—pituitary gland—germ cell cancer	0.00292	0.0136	CbGeAlD
Ceftriaxone—GLUL—medulla oblongata—germ cell cancer	0.00282	0.0132	CbGeAlD
Ceftriaxone—SLC22A8—trigeminal ganglion—germ cell cancer	0.00271	0.0127	CbGeAlD
Ceftriaxone—GLUL—adrenal gland—germ cell cancer	0.00261	0.0122	CbGeAlD
Ceftriaxone—GLUL—midbrain—germ cell cancer	0.00257	0.012	CbGeAlD
Ceftriaxone—GLUL—bone marrow—germ cell cancer	0.00252	0.0118	CbGeAlD
Ceftriaxone—GLUL—spinal cord—germ cell cancer	0.00251	0.0117	CbGeAlD
Ceftriaxone—GLUL—female gonad—germ cell cancer	0.00243	0.0114	CbGeAlD
Ceftriaxone—SLC22A11—endocrine gland—germ cell cancer	0.00238	0.0111	CbGeAlD
Ceftriaxone—SLC22A8—eye—germ cell cancer	0.00234	0.0109	CbGeAlD
Ceftriaxone—GLUL—endocrine gland—germ cell cancer	0.00226	0.0106	CbGeAlD
Ceftriaxone—GLUL—head—germ cell cancer	0.00223	0.0104	CbGeAlD
Ceftriaxone—GLUL—testis—germ cell cancer	0.00216	0.0101	CbGeAlD
Ceftriaxone—Phlebitis—Ifosfamide—germ cell cancer	0.00216	0.00619	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Ifosfamide—germ cell cancer	0.00214	0.00616	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00212	0.0061	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00206	0.0059	CcSEcCtD
Ceftriaxone—SLC15A2—retina—germ cell cancer	0.00201	0.0094	CbGeAlD
Ceftriaxone—GLUL—cerebellum—germ cell cancer	0.00199	0.0093	CbGeAlD
Ceftriaxone—Renal impairment—Ifosfamide—germ cell cancer	0.00195	0.0056	CcSEcCtD
Ceftriaxone—Candida infection—Etoposide—germ cell cancer	0.00193	0.00554	CcSEcCtD
Ceftriaxone—SLC15A1—endocrine gland—germ cell cancer	0.00187	0.00873	CbGeAlD
Ceftriaxone—Phlebitis—Cisplatin—germ cell cancer	0.00186	0.00533	CcSEcCtD
Ceftriaxone—SLC15A2—telencephalon—germ cell cancer	0.00185	0.00865	CbGeAlD
Ceftriaxone—Agranulocytosis—Vinblastine—germ cell cancer	0.00185	0.00531	CcSEcCtD
Ceftriaxone—Bronchospasm—Bleomycin—germ cell cancer	0.00185	0.0053	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00182	0.00524	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00182	0.00524	CcSEcCtD
Ceftriaxone—Haemoglobin—Vinblastine—germ cell cancer	0.00179	0.00513	CcSEcCtD
Ceftriaxone—Haemorrhage—Vinblastine—germ cell cancer	0.00178	0.00511	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00177	0.00509	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00174	0.00499	CcSEcCtD
Ceftriaxone—Phlebitis—Etoposide—germ cell cancer	0.0017	0.00489	CcSEcCtD
Ceftriaxone—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.0017	0.168	CbGpPWpGaD
Ceftriaxone—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00167	0.0048	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00165	0.00475	CcSEcCtD
Ceftriaxone—Neutropenia—Dactinomycin—germ cell cancer	0.00164	0.0047	CcSEcCtD
Ceftriaxone—Stomatitis—Bleomycin—germ cell cancer	0.00163	0.00469	CcSEcCtD
Ceftriaxone—GLUL—brain—germ cell cancer	0.00162	0.00755	CbGeAlD
Ceftriaxone—ALB—adrenal gland—germ cell cancer	0.00161	0.00754	CbGeAlD
Ceftriaxone—SLC22A6—brain—germ cell cancer	0.00161	0.0075	CbGeAlD
Ceftriaxone—Haematuria—Bleomycin—germ cell cancer	0.0016	0.00458	CcSEcCtD
Ceftriaxone—Bronchospasm—Ifosfamide—germ cell cancer	0.00158	0.00453	CcSEcCtD
Ceftriaxone—Pancreatitis—Ifosfamide—germ cell cancer	0.00157	0.00452	CcSEcCtD
Ceftriaxone—Fungal infection—Methotrexate—germ cell cancer	0.00157	0.0045	CcSEcCtD
Ceftriaxone—GLUL—lymph node—germ cell cancer	0.00156	0.0073	CbGeAlD
Ceftriaxone—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00155	0.00444	CcSEcCtD
Ceftriaxone—Stomatitis—Dactinomycin—germ cell cancer	0.00152	0.00437	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00152	0.00435	CcSEcCtD
Ceftriaxone—Haemoglobin—Bleomycin—germ cell cancer	0.00151	0.00434	CcSEcCtD
Ceftriaxone—SLC15A2—pituitary gland—germ cell cancer	0.00151	0.00704	CbGeAlD
Ceftriaxone—Haemorrhage—Bleomycin—germ cell cancer	0.0015	0.00431	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Cisplatin—germ cell cancer	0.0015	0.00431	CcSEcCtD
Ceftriaxone—Agranulocytosis—Dactinomycin—germ cell cancer	0.00146	0.00418	CcSEcCtD
Ceftriaxone—SLC15A2—medulla oblongata—germ cell cancer	0.00146	0.0068	CbGeAlD
Ceftriaxone—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00144	0.00414	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Vinblastine—germ cell cancer	0.00144	0.00413	CcSEcCtD
Ceftriaxone—Anaemia—Vinblastine—germ cell cancer	0.00143	0.00411	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00142	0.00407	CcSEcCtD
Ceftriaxone—Renal failure—Ifosfamide—germ cell cancer	0.00141	0.00404	CcSEcCtD
Ceftriaxone—Malaise—Vinblastine—germ cell cancer	0.0014	0.00401	CcSEcCtD
Ceftriaxone—Flushing—Bleomycin—germ cell cancer	0.00139	0.004	CcSEcCtD
Ceftriaxone—Stomatitis—Ifosfamide—germ cell cancer	0.00139	0.004	CcSEcCtD
Ceftriaxone—Leukopenia—Vinblastine—germ cell cancer	0.00139	0.00398	CcSEcCtD
Ceftriaxone—Proteinuria—Methotrexate—germ cell cancer	0.00138	0.00395	CcSEcCtD
Ceftriaxone—Haematuria—Ifosfamide—germ cell cancer	0.00136	0.00392	CcSEcCtD
Ceftriaxone—Protein urine present—Methotrexate—germ cell cancer	0.00136	0.0039	CcSEcCtD
Ceftriaxone—Pancreatitis—Cisplatin—germ cell cancer	0.00136	0.00389	CcSEcCtD
Ceftriaxone—Chills—Bleomycin—germ cell cancer	0.00135	0.00387	CcSEcCtD
Ceftriaxone—Sweating increased—Cisplatin—germ cell cancer	0.00135	0.00387	CcSEcCtD
Ceftriaxone—SLC15A2—adrenal gland—germ cell cancer	0.00135	0.00629	CbGeAlD
Ceftriaxone—Convulsion—Vinblastine—germ cell cancer	0.00134	0.00385	CcSEcCtD
Ceftriaxone—Agranulocytosis—Ifosfamide—germ cell cancer	0.00134	0.00383	CcSEcCtD
Ceftriaxone—ALB—testis—germ cell cancer	0.00133	0.00623	CbGeAlD
Ceftriaxone—SLC15A2—midbrain—germ cell cancer	0.00133	0.00621	CbGeAlD
Ceftriaxone—SLC22A8—head—germ cell cancer	0.00133	0.0062	CbGeAlD
Ceftriaxone—Erythema multiforme—Dactinomycin—germ cell cancer	0.00133	0.0038	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00132	0.00379	CcSEcCtD
Ceftriaxone—Glossitis—Methotrexate—germ cell cancer	0.00131	0.00377	CcSEcCtD
Ceftriaxone—Oliguria—Methotrexate—germ cell cancer	0.00131	0.00377	CcSEcCtD
Ceftriaxone—Discomfort—Vinblastine—germ cell cancer	0.0013	0.00374	CcSEcCtD
Ceftriaxone—Flushing—Dactinomycin—germ cell cancer	0.0013	0.00373	CcSEcCtD
Ceftriaxone—SLC15A2—spinal cord—germ cell cancer	0.0013	0.00606	CbGeAlD
Ceftriaxone—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00129	0.128	CbGpPWpGaD
Ceftriaxone—Haemoglobin—Ifosfamide—germ cell cancer	0.00129	0.00371	CcSEcCtD
Ceftriaxone—Haemorrhage—Ifosfamide—germ cell cancer	0.00128	0.00369	CcSEcCtD
Ceftriaxone—Chills—Dactinomycin—germ cell cancer	0.00126	0.00361	CcSEcCtD
Ceftriaxone—SLC15A2—female gonad—germ cell cancer	0.00126	0.00587	CbGeAlD
Ceftriaxone—Bronchospasm—Etoposide—germ cell cancer	0.00125	0.00358	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Vinblastine—germ cell cancer	0.00124	0.00355	CcSEcCtD
Ceftriaxone—Sweating increased—Etoposide—germ cell cancer	0.00123	0.00354	CcSEcCtD
Ceftriaxone—Erythema multiforme—Ifosfamide—germ cell cancer	0.00121	0.00349	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Bleomycin—germ cell cancer	0.00121	0.00349	CcSEcCtD
Ceftriaxone—Renal failure—Cisplatin—germ cell cancer	0.00121	0.00348	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Methotrexate—germ cell cancer	0.00121	0.00347	CcSEcCtD
Ceftriaxone—Anaemia—Bleomycin—germ cell cancer	0.00121	0.00347	CcSEcCtD
Ceftriaxone—Stomatitis—Cisplatin—germ cell cancer	0.0012	0.00345	CcSEcCtD
Ceftriaxone—Flushing—Ifosfamide—germ cell cancer	0.00119	0.00342	CcSEcCtD
Ceftriaxone—Neutropenia—Etoposide—germ cell cancer	0.00119	0.0034	CcSEcCtD
Ceftriaxone—Malaise—Bleomycin—germ cell cancer	0.00118	0.00339	CcSEcCtD
Ceftriaxone—Leukopenia—Bleomycin—germ cell cancer	0.00117	0.00336	CcSEcCtD
Ceftriaxone—SLC15A2—endocrine gland—germ cell cancer	0.00117	0.00546	CbGeAlD
Ceftriaxone—SLC15A2—head—germ cell cancer	0.00115	0.00539	CbGeAlD
Ceftriaxone—Chills—Ifosfamide—germ cell cancer	0.00115	0.00331	CcSEcCtD
Ceftriaxone—Vaginal infection—Methotrexate—germ cell cancer	0.00114	0.00328	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Methotrexate—germ cell cancer	0.00114	0.00326	CcSEcCtD
Ceftriaxone—Paraesthesia—Vinblastine—germ cell cancer	0.00114	0.00326	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00113	0.00325	CcSEcCtD
Ceftriaxone—Anaemia—Dactinomycin—germ cell cancer	0.00113	0.00324	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00112	0.00322	CcSEcCtD
Ceftriaxone—SLC15A2—testis—germ cell cancer	0.00111	0.0052	CbGeAlD
Ceftriaxone—Renal failure—Etoposide—germ cell cancer	0.00111	0.00319	CcSEcCtD
Ceftriaxone—Stomatitis—Etoposide—germ cell cancer	0.0011	0.00316	CcSEcCtD
Ceftriaxone—Jaundice—Etoposide—germ cell cancer	0.0011	0.00316	CcSEcCtD
Ceftriaxone—Discomfort—Bleomycin—germ cell cancer	0.0011	0.00316	CcSEcCtD
Ceftriaxone—Malaise—Dactinomycin—germ cell cancer	0.0011	0.00316	CcSEcCtD
Ceftriaxone—Leukopenia—Dactinomycin—germ cell cancer	0.00109	0.00314	CcSEcCtD
Ceftriaxone—Pain—Vinblastine—germ cell cancer	0.00108	0.0031	CcSEcCtD
Ceftriaxone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00108	0.107	CbGpPWpGaD
Ceftriaxone—Anaphylactic shock—Bleomycin—germ cell cancer	0.00107	0.00307	CcSEcCtD
Ceftriaxone—Oedema—Bleomycin—germ cell cancer	0.00107	0.00307	CcSEcCtD
Ceftriaxone—Infection—Bleomycin—germ cell cancer	0.00106	0.00305	CcSEcCtD
Ceftriaxone—Agranulocytosis—Etoposide—germ cell cancer	0.00105	0.00303	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Bleomycin—germ cell cancer	0.00105	0.003	CcSEcCtD
Ceftriaxone—Feeling abnormal—Vinblastine—germ cell cancer	0.00104	0.00299	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00104	0.00298	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00103	0.00297	CcSEcCtD
Ceftriaxone—Anaemia—Ifosfamide—germ cell cancer	0.00103	0.00297	CcSEcCtD
Ceftriaxone—SLC15A2—cerebellum—germ cell cancer	0.00103	0.0048	CbGeAlD
Ceftriaxone—Flushing—Cisplatin—germ cell cancer	0.00103	0.00295	CcSEcCtD
Ceftriaxone—Agitation—Ifosfamide—germ cell cancer	0.00103	0.00295	CcSEcCtD
Ceftriaxone—Discomfort—Dactinomycin—germ cell cancer	0.00103	0.00295	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Methotrexate—germ cell cancer	0.00101	0.00291	CcSEcCtD
Ceftriaxone—Malaise—Ifosfamide—germ cell cancer	0.00101	0.00289	CcSEcCtD
Ceftriaxone—ALB—brain—germ cell cancer	0.001	0.00468	CbGeAlD
Ceftriaxone—Leukopenia—Ifosfamide—germ cell cancer	0.001	0.00287	CcSEcCtD
Ceftriaxone—Abdominal pain—Vinblastine—germ cell cancer	0.000999	0.00287	CcSEcCtD
Ceftriaxone—Oedema—Dactinomycin—germ cell cancer	0.000996	0.00286	CcSEcCtD
Ceftriaxone—Infection—Dactinomycin—germ cell cancer	0.000989	0.00284	CcSEcCtD
Ceftriaxone—Palpitations—Ifosfamide—germ cell cancer	0.000988	0.00284	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000975	0.0028	CcSEcCtD
Ceftriaxone—Convulsion—Ifosfamide—germ cell cancer	0.000969	0.00278	CcSEcCtD
Ceftriaxone—ALB—lymph node—germ cell cancer	0.000968	0.00452	CbGeAlD
Ceftriaxone—SLC22A8—brain—germ cell cancer	0.000962	0.00449	CbGeAlD
Ceftriaxone—Erythema multiforme—Etoposide—germ cell cancer	0.000959	0.00275	CcSEcCtD
Ceftriaxone—Paraesthesia—Bleomycin—germ cell cancer	0.000959	0.00275	CcSEcCtD
Ceftriaxone—Flatulence—Cisplatin—germ cell cancer	0.00095	0.00273	CcSEcCtD
Ceftriaxone—Flushing—Etoposide—germ cell cancer	0.000941	0.0027	CcSEcCtD
Ceftriaxone—Discomfort—Ifosfamide—germ cell cancer	0.000941	0.0027	CcSEcCtD
Ceftriaxone—Hypersensitivity—Vinblastine—germ cell cancer	0.000931	0.00267	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000931	0.00267	CcSEcCtD
Ceftriaxone—Pain—Bleomycin—germ cell cancer	0.000913	0.00262	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000913	0.00262	CcSEcCtD
Ceftriaxone—Oedema—Ifosfamide—germ cell cancer	0.000913	0.00262	CcSEcCtD
Ceftriaxone—Chills—Etoposide—germ cell cancer	0.00091	0.00261	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000908	0.00261	CcSEcCtD
Ceftriaxone—Infection—Ifosfamide—germ cell cancer	0.000907	0.0026	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Cisplatin—germ cell cancer	0.000894	0.00257	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000893	0.00257	CcSEcCtD
Ceftriaxone—Anaemia—Cisplatin—germ cell cancer	0.000891	0.00256	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000882	0.00253	CcSEcCtD
Ceftriaxone—Feeling abnormal—Bleomycin—germ cell cancer	0.00088	0.00253	CcSEcCtD
Ceftriaxone—Malaise—Cisplatin—germ cell cancer	0.000869	0.0025	CcSEcCtD
Ceftriaxone—Diarrhoea—Vinblastine—germ cell cancer	0.000865	0.00248	CcSEcCtD
Ceftriaxone—Dysgeusia—Etoposide—germ cell cancer	0.000865	0.00248	CcSEcCtD
Ceftriaxone—Leukopenia—Cisplatin—germ cell cancer	0.000863	0.00248	CcSEcCtD
Ceftriaxone—Pain—Dactinomycin—germ cell cancer	0.000852	0.00244	CcSEcCtD
Ceftriaxone—Urticaria—Bleomycin—germ cell cancer	0.000848	0.00244	CcSEcCtD
Ceftriaxone—Body temperature increased—Bleomycin—germ cell cancer	0.000844	0.00242	CcSEcCtD
Ceftriaxone—Dizziness—Vinblastine—germ cell cancer	0.000836	0.0024	CcSEcCtD
Ceftriaxone—SLC15A2—brain—germ cell cancer	0.000836	0.0039	CbGeAlD
Ceftriaxone—Convulsion—Cisplatin—germ cell cancer	0.000835	0.0024	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—germ cell cancer	0.000826	0.00237	CcSEcCtD
Ceftriaxone—Feeling abnormal—Dactinomycin—germ cell cancer	0.000821	0.00236	CcSEcCtD
Ceftriaxone—Paraesthesia—Ifosfamide—germ cell cancer	0.000819	0.00235	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Etoposide—germ cell cancer	0.000819	0.00235	CcSEcCtD
Ceftriaxone—Anaemia—Etoposide—germ cell cancer	0.000816	0.00234	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000814	0.00234	CcSEcCtD
Ceftriaxone—Discomfort—Cisplatin—germ cell cancer	0.000811	0.00233	CcSEcCtD
Ceftriaxone—SLC15A2—lymph node—germ cell cancer	0.000808	0.00377	CbGeAlD
Ceftriaxone—Vomiting—Vinblastine—germ cell cancer	0.000804	0.00231	CcSEcCtD
Ceftriaxone—Malaise—Etoposide—germ cell cancer	0.000796	0.00229	CcSEcCtD
Ceftriaxone—Headache—Vinblastine—germ cell cancer	0.000792	0.00227	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000791	0.00227	CcSEcCtD
Ceftriaxone—Leukopenia—Etoposide—germ cell cancer	0.00079	0.00227	CcSEcCtD
Ceftriaxone—Abdominal pain—Dactinomycin—germ cell cancer	0.000787	0.00226	CcSEcCtD
Ceftriaxone—Body temperature increased—Dactinomycin—germ cell cancer	0.000787	0.00226	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cisplatin—germ cell cancer	0.000787	0.00226	CcSEcCtD
Ceftriaxone—Oedema—Cisplatin—germ cell cancer	0.000787	0.00226	CcSEcCtD
Ceftriaxone—Hypersensitivity—Bleomycin—germ cell cancer	0.000787	0.00226	CcSEcCtD
Ceftriaxone—Infection—Cisplatin—germ cell cancer	0.000782	0.00224	CcSEcCtD
Ceftriaxone—Pain—Ifosfamide—germ cell cancer	0.00078	0.00224	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cisplatin—germ cell cancer	0.00077	0.00221	CcSEcCtD
Ceftriaxone—Convulsion—Etoposide—germ cell cancer	0.000765	0.0022	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Cisplatin—germ cell cancer	0.000761	0.00218	CcSEcCtD
Ceftriaxone—Pruritus—Bleomycin—germ cell cancer	0.000755	0.00217	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ifosfamide—germ cell cancer	0.000752	0.00216	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—germ cell cancer	0.000752	0.00216	CcSEcCtD
Ceftriaxone—Nausea—Vinblastine—germ cell cancer	0.000751	0.00216	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000746	0.00214	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—germ cell cancer	0.000744	0.00214	CcSEcCtD
Ceftriaxone—Discomfort—Etoposide—germ cell cancer	0.000743	0.00213	CcSEcCtD
Ceftriaxone—Hypersensitivity—Dactinomycin—germ cell cancer	0.000734	0.00211	CcSEcCtD
Ceftriaxone—Urticaria—Ifosfamide—germ cell cancer	0.000725	0.00208	CcSEcCtD
Ceftriaxone—Abdominal pain—Ifosfamide—germ cell cancer	0.000721	0.00207	CcSEcCtD
Ceftriaxone—Body temperature increased—Ifosfamide—germ cell cancer	0.000721	0.00207	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Etoposide—germ cell cancer	0.000721	0.00207	CcSEcCtD
Ceftriaxone—Infection—Etoposide—germ cell cancer	0.000716	0.00206	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—germ cell cancer	0.00071	0.00204	CcSEcCtD
Ceftriaxone—Paraesthesia—Cisplatin—germ cell cancer	0.000706	0.00203	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Etoposide—germ cell cancer	0.000706	0.00203	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Etoposide—germ cell cancer	0.000697	0.002	CcSEcCtD
Ceftriaxone—Diarrhoea—Dactinomycin—germ cell cancer	0.000681	0.00196	CcSEcCtD
Ceftriaxone—Vomiting—Bleomycin—germ cell cancer	0.000679	0.00195	CcSEcCtD
Ceftriaxone—Rash—Bleomycin—germ cell cancer	0.000673	0.00193	CcSEcCtD
Ceftriaxone—Pain—Cisplatin—germ cell cancer	0.000673	0.00193	CcSEcCtD
Ceftriaxone—Dermatitis—Bleomycin—germ cell cancer	0.000673	0.00193	CcSEcCtD
Ceftriaxone—Hypersensitivity—Ifosfamide—germ cell cancer	0.000672	0.00193	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000671	0.00193	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—germ cell cancer	0.000665	0.00191	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—germ cell cancer	0.00066	0.00189	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cisplatin—germ cell cancer	0.000648	0.00186	CcSEcCtD
Ceftriaxone—Paraesthesia—Etoposide—germ cell cancer	0.000647	0.00186	CcSEcCtD
Ceftriaxone—Pruritus—Ifosfamide—germ cell cancer	0.000646	0.00185	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—germ cell cancer	0.000645	0.00185	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—germ cell cancer	0.000638	0.00183	CcSEcCtD
Ceftriaxone—Nausea—Bleomycin—germ cell cancer	0.000634	0.00182	CcSEcCtD
Ceftriaxone—Vomiting—Dactinomycin—germ cell cancer	0.000633	0.00182	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—germ cell cancer	0.000632	0.00181	CcSEcCtD
Ceftriaxone—Rash—Dactinomycin—germ cell cancer	0.000628	0.0018	CcSEcCtD
Ceftriaxone—Diarrhoea—Ifosfamide—germ cell cancer	0.000624	0.00179	CcSEcCtD
Ceftriaxone—Body temperature increased—Cisplatin—germ cell cancer	0.000622	0.00179	CcSEcCtD
Ceftriaxone—Pain—Etoposide—germ cell cancer	0.000616	0.00177	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—germ cell cancer	0.000611	0.00175	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—germ cell cancer	0.000608	0.00174	CcSEcCtD
Ceftriaxone—Dizziness—Ifosfamide—germ cell cancer	0.000603	0.00173	CcSEcCtD
Ceftriaxone—Feeling abnormal—Etoposide—germ cell cancer	0.000594	0.00171	CcSEcCtD
Ceftriaxone—Nausea—Dactinomycin—germ cell cancer	0.000592	0.0017	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000589	0.00169	CcSEcCtD
Ceftriaxone—Vomiting—Ifosfamide—germ cell cancer	0.00058	0.00167	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cisplatin—germ cell cancer	0.00058	0.00166	CcSEcCtD
Ceftriaxone—Rash—Ifosfamide—germ cell cancer	0.000575	0.00165	CcSEcCtD
Ceftriaxone—Dermatitis—Ifosfamide—germ cell cancer	0.000575	0.00165	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—germ cell cancer	0.000575	0.00165	CcSEcCtD
Ceftriaxone—Urticaria—Etoposide—germ cell cancer	0.000573	0.00164	CcSEcCtD
Ceftriaxone—Abdominal pain—Etoposide—germ cell cancer	0.00057	0.00164	CcSEcCtD
Ceftriaxone—Body temperature increased—Etoposide—germ cell cancer	0.00057	0.00164	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—germ cell cancer	0.000545	0.00157	CcSEcCtD
Ceftriaxone—Nausea—Ifosfamide—germ cell cancer	0.000542	0.00156	CcSEcCtD
Ceftriaxone—Diarrhoea—Cisplatin—germ cell cancer	0.000538	0.00155	CcSEcCtD
Ceftriaxone—Hypersensitivity—Etoposide—germ cell cancer	0.000531	0.00152	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—germ cell cancer	0.000518	0.00149	CcSEcCtD
Ceftriaxone—Pruritus—Etoposide—germ cell cancer	0.00051	0.00146	CcSEcCtD
Ceftriaxone—Vomiting—Cisplatin—germ cell cancer	0.0005	0.00144	CcSEcCtD
Ceftriaxone—Rash—Cisplatin—germ cell cancer	0.000496	0.00142	CcSEcCtD
Ceftriaxone—Dermatitis—Cisplatin—germ cell cancer	0.000496	0.00142	CcSEcCtD
Ceftriaxone—Diarrhoea—Etoposide—germ cell cancer	0.000493	0.00142	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—germ cell cancer	0.000491	0.00141	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—germ cell cancer	0.000489	0.0014	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—germ cell cancer	0.000477	0.00137	CcSEcCtD
Ceftriaxone—Dizziness—Etoposide—germ cell cancer	0.000477	0.00137	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—germ cell cancer	0.000473	0.00136	CcSEcCtD
Ceftriaxone—Nausea—Cisplatin—germ cell cancer	0.000467	0.00134	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—germ cell cancer	0.000458	0.00132	CcSEcCtD
Ceftriaxone—Vomiting—Etoposide—germ cell cancer	0.000458	0.00132	CcSEcCtD
Ceftriaxone—Rash—Etoposide—germ cell cancer	0.000454	0.0013	CcSEcCtD
Ceftriaxone—Dermatitis—Etoposide—germ cell cancer	0.000454	0.0013	CcSEcCtD
Ceftriaxone—Headache—Etoposide—germ cell cancer	0.000452	0.0013	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—germ cell cancer	0.000445	0.00128	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—germ cell cancer	0.000432	0.00124	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—germ cell cancer	0.000429	0.00123	CcSEcCtD
Ceftriaxone—Nausea—Etoposide—germ cell cancer	0.000428	0.00123	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—germ cell cancer	0.000423	0.00121	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—germ cell cancer	0.000417	0.0012	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—germ cell cancer	0.000388	0.00111	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—germ cell cancer	0.00038	0.00109	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—germ cell cancer	0.000369	0.00106	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—germ cell cancer	0.000356	0.00102	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000353	0.00101	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000345	0.0341	CbGpPWpGaD
Ceftriaxone—Urticaria—Methotrexate—germ cell cancer	0.000343	0.000985	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—germ cell cancer	0.000341	0.00098	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—germ cell cancer	0.000341	0.00098	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00034	0.0336	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Methotrexate—germ cell cancer	0.000318	0.000913	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—germ cell cancer	0.000305	0.000877	CcSEcCtD
Ceftriaxone—ALB—Transport of organic anions—AVP—germ cell cancer	0.0003	0.0297	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Methotrexate—germ cell cancer	0.000295	0.000848	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—germ cell cancer	0.000285	0.00082	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—germ cell cancer	0.000274	0.000788	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—germ cell cancer	0.000272	0.000781	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—germ cell cancer	0.000272	0.000781	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—germ cell cancer	0.00027	0.000776	CcSEcCtD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000263	0.026	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000259	0.0256	CbGpPWpGaD
Ceftriaxone—Nausea—Methotrexate—germ cell cancer	0.000256	0.000736	CcSEcCtD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00022	0.0217	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000216	0.0214	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000157	0.0155	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000154	0.0153	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000145	0.0143	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000143	0.0141	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000134	0.0133	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000132	0.0131	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—CD9—germ cell cancer	0.000129	0.0128	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000123	0.0122	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000122	0.012	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00012	0.0118	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000118	0.0116	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000113	0.0111	CbGpPWpGaD
Ceftriaxone—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000111	0.011	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000104	0.0103	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—HRAS—germ cell cancer	0.000101	0.00994	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.98e-05	0.00987	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.83e-05	0.00972	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.29e-05	0.00918	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.97e-05	0.00788	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.85e-05	0.00776	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.75e-05	0.00766	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—SLC2A3—germ cell cancer	7.49e-05	0.00741	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—SLC22A3—germ cell cancer	7.38e-05	0.0073	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.36e-05	0.00728	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.25e-05	0.00717	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	7.23e-05	0.00715	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.83e-05	0.00675	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.73e-05	0.00665	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.68e-05	0.0066	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.2e-05	0.00613	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.08e-05	0.00601	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CRABP1—germ cell cancer	6.02e-05	0.00595	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.99e-05	0.00592	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	5.74e-05	0.00567	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.51e-05	0.00545	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—HRAS—germ cell cancer	5.4e-05	0.00534	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	5.19e-05	0.00513	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	5.11e-05	0.00505	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.07e-05	0.00501	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5e-05	0.00494	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.6e-05	0.00455	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—HRAS—germ cell cancer	4.14e-05	0.00409	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.03e-05	0.00398	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—AVP—germ cell cancer	3.67e-05	0.00363	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.4e-05	0.00336	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AVP—germ cell cancer	3.15e-05	0.00311	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD9—germ cell cancer	2.96e-05	0.00292	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	2.8e-05	0.00277	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.64e-05	0.00261	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.6e-05	0.00257	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	2.39e-05	0.00236	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	2.34e-05	0.00231	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TP53—germ cell cancer	2.26e-05	0.00223	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.23e-05	0.0022	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A3—germ cell cancer	1.23e-05	0.00122	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC22A3—germ cell cancer	1.22e-05	0.0012	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	1.22e-05	0.0012	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CRABP1—germ cell cancer	9.91e-06	0.00098	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TP53—germ cell cancer	4.43e-06	0.000438	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HRAS—germ cell cancer	4.24e-06	0.000419	CbGpPWpGaD
